New trial for Lung NETs (lung neuroendocrine tumors) - 1290888

Would you be interested to participate in a clinical trial evaluating the efficacy and safety of an investigative drug for Lung Neuroendocrine Tumors (Lung NETs)?

This clinical study is being conducted to evaluate an investigative treatment for Lung Neuroendocrine Tumors (Lung NETs). You may have heard of this condition being called Lung Carcinoid Tumors, Bronchial NETs, or Pulmonary NETs.

A total of 216 patients will be a part of this global study, which has been approved by the FDA and relevant ethics committees. We are looking for both males and females, aged 18 years or older, who are diagnosed with a neuroendocrine tumor of the lung (Lung NET).

Read more about the trial here.